On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed Philadelphia chromosome-positive chronic […]

Delivery Method: VIA UPS Reference #: 320-25-06 Product: Drugs Recipient: Recipient Name Mr. Sudhir Shah Recipient Title President Choice All Natural, Inc. dba Om Botanical 1019 […]

Delivery Method: VIA UPS Reference #: 320-25-07 Product: Drugs Recipient: Recipient Name Mr. Yucel Teker Recipient Title General Manager/Chairman of the Board MedOffice Saglik Endustri Anonim […]

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Jerry M. Duren Recipient Title Owner Duren Health Mart Pharmacy 215 Dexter L. Woods Memorial Blvd.Waynesboro, TN […]

For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

Drug Disposal: Drug Take Back Options The best way to safely dispose of most types of unused or expired medicines Medicine take back options are the […]

On This Page Date: December 4, 2024 Time: 8:00 AM – 3:00 PM ET Location: Event Location FDA HeadquartersFDA headquarters in White Oak, MD 10903 New […]

Minimum Inhibitory Concentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacteralesa ≤ 0.25 0.5 ≥ 1.0 ≥ 19 16-18 ≤ 15 […]

Action The U.S. Food and Drug Administration has approved Orlynvah (sulopenem etzadroxil and probenecid) oral tablets for the treatment of uncomplicated urinary tract infection(s) (uUTI) caused […]